XML 75 R65.htm IDEA: XBRL DOCUMENT v3.25.2
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 17, 2025
USD ($)
Sep. 16, 2024
USD ($)
Jun. 19, 2024
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
intangibleAsset
Finite-Lived Intangible Assets [Line Items]                
Number of intangible assets acquired | intangibleAsset               2
Royalty payment percentage     3.125%          
Buyout period     6 months          
Payments for royalties $ 17,300,000              
Amortization of intangible assets       $ 21,100,000 $ 13,000,000.0 $ 41,800,000 $ 25,900,000  
Gross Carrying Amount       929,892,000   929,892,000   $ 893,825,000
Impairment of indefinite lived intangible assets       0 $ 0 $ 0 $ 0  
Buy Out Option                
Finite-Lived Intangible Assets [Line Items]                
Remaining estimated useful lives 12 years              
Acquired ANDAs intangible assets                
Finite-Lived Intangible Assets [Line Items]                
Intangible assets acquired       $ 2,600,000        
Remaining estimated useful lives       7 years   7 years    
Gross Carrying Amount       $ 213,514,000   $ 213,514,000   $ 210,497,000
Acquired ANDAs intangible assets | Reclassification Of Assets On Completion Of Project And Launch Of Related Products                
Finite-Lived Intangible Assets [Line Items]                
Remaining estimated useful lives       10 years   10 years    
Acquired ANDAs intangible assets | In process research and development | Reclassification Of Assets On Completion Of Project And Launch Of Related Products                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Amount       $ 15,800,000   $ 15,800,000    
Alimera Sciences, Inc                
Finite-Lived Intangible Assets [Line Items]                
Remaining estimated useful lives               12 years
Alimera Sciences, Inc | YUTIQ                
Finite-Lived Intangible Assets [Line Items]                
Intangible assets acquired   $ 170,000           $ 170,000,000
Remaining estimated useful lives   12 years            
Alimera Sciences, Inc | ILUVIEN                
Finite-Lived Intangible Assets [Line Items]                
Intangible assets acquired   $ 230,000           $ 230,000,000
Remaining estimated useful lives   12 years